UvarigrinCAS# 200563-11-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 200563-11-7 | SDF | Download SDF |
PubChem ID | 78384572 | Appearance | Powder |
Formula | C37H68O6 | M.Wt | 608.94 |
Type of Compound | Lipids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 4-[13,15-dihydroxy-15-[5-(1-hydroxytridecyl)oxolan-2-yl]pentadecyl]-2-methyl-2H-furan-5-one | ||
SMILES | CCCCCCCCCCCCC(C1CCC(O1)C(CC(CCCCCCCCCCCCC2=CC(OC2=O)C)O)O)O | ||
Standard InChIKey | ADPAPZVYVYEBGS-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C37H68O6/c1-3-4-5-6-7-8-13-16-19-22-25-33(39)35-26-27-36(43-35)34(40)29-32(38)24-21-18-15-12-10-9-11-14-17-20-23-31-28-30(2)42-37(31)41/h28,30,32-36,38-40H,3-27,29H2,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Uvarigrin induces apoptosis in KBv200 cells and KB cells probably through a mitochondria-dependent pathway. 2. Uvarigrin shows cytotoxicity against HCT-8, Bel7402 and A2780 human tumor cell lines at ED50 levels of 0.15, 0.21 and 0.41 microgram/ml, respectively. |
Uvarigrin Dilution Calculator
Uvarigrin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.6422 mL | 8.211 mL | 16.422 mL | 32.844 mL | 41.0549 mL |
5 mM | 0.3284 mL | 1.6422 mL | 3.2844 mL | 6.5688 mL | 8.211 mL |
10 mM | 0.1642 mL | 0.8211 mL | 1.6422 mL | 3.2844 mL | 4.1055 mL |
50 mM | 0.0328 mL | 0.1642 mL | 0.3284 mL | 0.6569 mL | 0.8211 mL |
100 mM | 0.0164 mL | 0.0821 mL | 0.1642 mL | 0.3284 mL | 0.4105 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4-Benzamido-2,5-diethoxybenzenediazonium
Catalog No.:BCN8579
CAS No.:5486-84-0
- Hexamethylquercetagetin
Catalog No.:BCN8578
CAS No.:1251-84-9
- Epitheaflagallin 3-O-gallate
Catalog No.:BCN8577
CAS No.:102067-92-5
- 5,6-Dehydroginsenoside Rd
Catalog No.:BCN8576
CAS No.:1268459-68-2
- Jionoside D
Catalog No.:BCN8575
CAS No.:120406-34-0
- Tectol
Catalog No.:BCN8574
CAS No.:24449-39-6
- Perisesaccharide B
Catalog No.:BCN8573
CAS No.:1095261-93-0
- 4'-O-Methylochnaflavone
Catalog No.:BCN8572
CAS No.:49619-87-6
- 2-Amino-3-carboxy-1,4-naphthoquinone
Catalog No.:BCN8571
CAS No.:173043-38-4
- Graveobioside A
Catalog No.:BCN8570
CAS No.:506410-53-3
- Gancaonin N
Catalog No.:BCN8569
CAS No.:129145-52-4
- Saikogenin D
Catalog No.:BCN8568
CAS No.:5573-16-0
- Isoginsenoside Rh3
Catalog No.:BCN8581
CAS No.:166040-90-0
- Isorosmanol
Catalog No.:BCN8582
CAS No.:93780-80-4
- Ligupurpuroside C
Catalog No.:BCN8583
CAS No.:1194056-33-1
- Lucidin 3-O-primeveroside
Catalog No.:BCN8584
CAS No.:29706-59-0
- Platycodin D3
Catalog No.:BCN8585
CAS No.:67884-03-1
- Sarracenin
Catalog No.:BCN8586
CAS No.:59653-37-1
- Glyasperin C
Catalog No.:BCN8587
CAS No.:142474-53-1
- Rubiayannone A
Catalog No.:BCN8588
CAS No.:517978-25-1
- Hydroquinidine
Catalog No.:BCN8589
CAS No.:1435-55-8
- Aaptamine
Catalog No.:BCN8590
CAS No.:85547-22-4
- Firmanoic acid
Catalog No.:BCN8591
CAS No.:107584-83-8
- Licoflavone B
Catalog No.:BCN8592
CAS No.:91433-17-9
[Studies on new cytotoxic annonaceous acetogenins from Uvaria grandiflora and absolute configurations].[Pubmed:11499032]
Yao Xue Xue Bao. 1997 Apr;32(4):286-93.
Two new cytotoxic annonaceous acetogenins, named Uvarigrin(1) and uvarigrandin A(3), were obtained from the roots of Uvaria grandiflora Roxb(Annonaceae). Based on X-ray analysis and Mosher's methodology, the overall absolute configuration of 1 was established as 15S, 17R, 18R, 21R, 22R, 36S. The absolute configuration of 3 was also resolved by Mosher's methodology. The relative configuration of the previously reported uvarigranin (2) was revised. Compound 1 showed cytotoxicity against HCT-8, Bel7402 and A2780 human tumor cell lines at ED50 levels of 0.15, 0.21 and 0.41 microgram.ml-1, respectively.
[Induction of apoptosis of tumor multidrug resistance cell by uvarigrin and its mechanism].[Pubmed:16758998]
Yao Xue Xue Bao. 2006 Mar;41(3):252-6.
AIM: To study the effect of Uvarigrin on mitochondrial dependent pathway during the apoptosis induced by it in MDR KBv200 cells and their parental sensitive KB cells. METHODS: MTT assay was used to detect the cytotoxic effect of Uvarigrin on KBv200 and KB cells. Annexin V FITC staining identified Uvarigrin-induced apoptosis in KBv200 and KB cells. These cells underwent incubation with DCFH-DA, or DiOC6, followed by flowcytometry for the measurement of reactive oxygen species (ROS) and mitochondrial membrane potential (deltapsim), respectively. The Western blotting analysis was performed on Caspase-9 activation. RESULTS: Uvarigrin inhibited the growth of KBv200 cells and KB cells in vitro. Most of the Uvarigrin-induced cells death was found to be due to apoptosis, as determined by Annexin V FITC staining. During the apoptosis, the level of ROS increased while the level of deltapsim decreased in a time-dependent manner. Uvarigrin triggered Caspase-9 activation. CONCLUSION: Uvarigrin induced apoptosis in KBv200 cells and KB cells probably through a mitochondria-dependent pathway.